Product Information
MESALAMINE DR 400 MG CAPSULE is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $2.3504 per EA under NDC 00093590786. Its NADAC has been published 363 times since Jul 17, 2019.
Strength
400 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093590786
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MESALAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA207873On Market Since
5/9/2019
Pharmacological Classes
Price Statistics
The NADAC for MESALAMINE DR 400 MG CAPSULE has been published 363 times since Jul 17, 2019, and over the history we have for it it has declined 8.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.3504 per EA |
|---|---|
| All-time high | $2.5848 (May 11, 2022) |
| All-time low | $1.5286 (Jul 17, 2024) |
| 52-week high | $2.4055 |
| 52-week low | $2.0896 |
| Median price | $2.1058 |
| Average price | $2.1049 |
| Largest weekly change | +29.8% (Aug 21, 2024) |
| Weeks tracked | 363 |
| Tracking since | Jul 17, 2019 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MESALAMINE DR 400 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for MESALAMINE DR 400 MG CAPSULE, manufactured by Teva Pharmaceuticals USA Inc., is $2.3504 per EA (NDC 00093590786), effective Jun 24, 2026.
How has the price of MESALAMINE DR 400 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for MESALAMINE DR 400 MG CAPSULE has declined 8.3%. It has been tracked across 363 weekly CMS publications since Jul 17, 2019.
What are the highest and lowest recorded NADAC prices for MESALAMINE DR 400 MG CAPSULE?
Since Jul 17, 2019, the NADAC for MESALAMINE DR 400 MG CAPSULE has ranged from a low of $1.5286 (Jul 17, 2024) to a high of $2.5848 (May 11, 2022), with a median of $2.1058 per EA.
Are there cheaper alternatives to MESALAMINE DR 400 MG CAPSULE?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as MESALAMINE DR 400 MG CAPSULE, but none are currently priced below it.
Who manufactures MESALAMINE DR 400 MG CAPSULE?
MESALAMINE DR 400 MG CAPSULE (NDC 00093590786) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification